Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma

被引:32
作者
Liu, Tang [1 ,2 ,3 ]
Shen, Jacson K. [1 ,2 ]
Li, Zhihong [3 ]
Choy, Edwin [1 ,2 ]
Hornicek, Francis J. [1 ,2 ]
Duan, Zhenfeng [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Orthopaed Surg, Sarcoma Biol Lab, 55 Fruit St,Jackson 1115, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, 55 Fruit St,Jackson 1115, Boston, MA 02114 USA
[3] Cent South Univ, Xiangya Hosp 2, Dept Orthopaed, 139 Renmin Rd, Changsha 410011, Hunan, Peoples R China
基金
美国国家卫生研究院;
关键词
CRISPR-Cas9; Sarcoma; Cancer modeling; Gene therapy; MOUSE MODEL; CHROMOSOMAL TRANSLOCATIONS; ANTITUMOR-ACTIVITY; CELLULAR-ORIGINS; NUCLEAR EXPORT; CANCER; P53; CRISPR/CAS9; TUMOR; EXPRESSION;
D O I
10.1016/j.canlet.2016.01.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sarcomas include some of the most aggressive tumors and typically respond poorly to chemotherapy. In recent years, specific gene fusion/mutations and gene over-expression/activation have been shown to drive sarcoma pathogenesis and development. These emerging genomic alterations may provide targets for novel therapeutic strategies and have the potential to transform sarcoma patient care. The RNA guided nuclease CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated protein-9 nuclease) is a convenient and versatile platform for site-specific genome editing and epigenome targeted modulation. Given that sarcoma is believed to develop as a result of genetic alterations in mesenchymal progenitor/stem cells, CRISPR-Cas9 genome editing technologies hold extensive application potentials in sarcoma models and therapies. We review the development and mechanisms of the CRISPR-Cas9 system in genome editing and introduce its application in sarcoma research and potential therapy in clinic. Additionally, we propose future directions and discuss the challenges faced with these applications, providing concise and enlightening information for readers interested in this area. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:109 / 118
页数:10
相关论文
共 50 条
[21]   Applications of CRISPR-Cas9 mediated genome engineering [J].
Yang X. .
Military Medical Research, 2 (1)
[22]   Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications [J].
Zhou, Lifang ;
Yao, Shaohua .
MOLECULAR BIOMEDICINE, 2023, 4 (01)
[23]   Principles of CRISPR-Cas9 technology: Advancements in genome editing and emerging trends in drug delivery [J].
Aljabali, Alaa A. A. ;
El-Tanani, Mohamed ;
Tambuwala, Murtaza M. .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 92
[24]   gRNA validation for wheat genome editing with the CRISPR-Cas9 system [J].
Arndell, Taj ;
Sharma, Niharika ;
Langridge, Peter ;
Baumann, Ute ;
Watson-Haigh, Nathan S. ;
Whitford, Ryan .
BMC BIOTECHNOLOGY, 2019, 19 (01)
[25]   CRISPR-Cas9 genome editing for cancer immunotherapy: opportunities and challenges [J].
Chen, Ming ;
Xu, Jiang ;
Zhou, Yang ;
Zhang, Silin ;
Zhu, Di .
BRIEFINGS IN FUNCTIONAL GENOMICS, 2020, 19 (03) :183-190
[26]   A REVIEW ON GENOME EDITING BY CRISPR-CAS9 TECHNIQUE FOR CANCER TREATMENT [J].
Khan, M. Niuz Morshed ;
Islam, K. Khaldun ;
Ashraf, A. ;
Barman, N. Chandra .
WORLD CANCER RESEARCH JOURNAL, 2020, 7
[27]   Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing [J].
Fang, Tianxu ;
Cao, Xiaona ;
Ibnat, Mysha ;
Chen, Guojun .
JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
[28]   A CRISPR-Cas9 System for Genome Editing of Fusarium proliferatum [J].
Ferrara, Massimo ;
Haidukowski, Miriam ;
Logrieco, Antonio F. ;
Leslie, John F. ;
Mule, Giuseppina .
SCIENTIFIC REPORTS, 2019, 9 (1)
[29]   CRISPR-Cas9 MEDIATED GENOME EDITING IN ESCHERICHIA COLI [J].
Al-Wawi, M. Z. ;
Hassan, R. M. ;
Mohamed, M. E. ;
Khan, M. F. ;
Magaogao, M. ;
Hossain, A. .
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2019, 10 (07) :3373-3377
[30]   Temperature effect on CRISPR-Cas9 mediated genome editing [J].
Xiang, Guanghai ;
Zhang, Xingying ;
An, Chenrui ;
Cheng, Chen ;
Wang, Haoyi .
JOURNAL OF GENETICS AND GENOMICS, 2017, 44 (04) :199-205